Perfil
Thomas E.
Jenkins is the founder.
He founded Elysium Therapeutics, Inc. in 2013 and currently holds the title of Chief Scientific Officer.
He also held the position of Chief Scientific Officer & Vice President-Research at Signature Therapeutics, Inc. In terms of education, Dr. Jenkins obtained a doctorate degree from Stanford University and an undergraduate degree from the University of Akron.
Cargos activos de Thomas E. Jenkins
| Empresas | Cargo | Inicio |
|---|---|---|
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Fundador | 01/01/2013 |
Antiguos cargos conocidos de Thomas E. Jenkins.
| Empresas | Cargo | Fin |
|---|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director Técnico/Científico/I+D | - |
Formación de Thomas E. Jenkins.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Akron
University of Akron Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
- Bolsa de valores
- Insiders
- Thomas E. Jenkins
















